Aspects described herein relate to edible compositions and methods for the enhancement of delivery of lipophilic active agents across the blood-brain barrier, particularly wherein the lipophilic active agent infused edible compositions produce greater concentrations of lipophilic active agents in subjects' central nervous system tissues as compared to control compositions. Further provided are methods for treating central nervous system disorders comprising administering the edible compositions to subjects in need thereof.
展开▼